Experimental Drug Combination Shows Promise for Cannabis Withdrawal Treatment
Camila Berriex
Summary
A small clinical trial demonstrates that a combination of nabilone and gabapentin may effectively reduce cannabis withdrawal symptoms in adults with moderate-to-severe cannabis use disorder. The experimental treatment showed significant improvements in symptom severity and overall discomfort compared to placebo. While results are encouraging, researchers emphasize the need for larger, longer studies to confirm efficacy and establish optimal dosing protocols. This represents an important step toward developing evidence-based pharmacological interventions for cannabis dependence, addressing a significant gap in addiction treatment options.
